Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 32 | 2024 | 2606 | 2.580 |
Why?
|
Acute Lung Injury | 11 | 2021 | 377 | 1.520 |
Why?
|
Endotoxemia | 11 | 2021 | 198 | 1.320 |
Why?
|
HMGA1a Protein | 4 | 2018 | 63 | 1.050 |
Why?
|
Critical Illness | 21 | 2024 | 2744 | 0.990 |
Why?
|
Interleukin-18 | 4 | 2023 | 251 | 0.940 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2015 | 512 | 0.700 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 183 | 0.670 |
Why?
|
Lung | 17 | 2024 | 10033 | 0.660 |
Why?
|
Ventilator-Induced Lung Injury | 5 | 2021 | 135 | 0.640 |
Why?
|
Blood Specimen Collection | 1 | 2020 | 238 | 0.630 |
Why?
|
Distamycins | 3 | 2010 | 10 | 0.610 |
Why?
|
Endotoxins | 5 | 2018 | 516 | 0.570 |
Why?
|
Pulmonary Alveoli | 2 | 2019 | 664 | 0.570 |
Why?
|
Intensive Care Units | 19 | 2024 | 3800 | 0.560 |
Why?
|
Iatrogenic Disease | 1 | 2020 | 553 | 0.550 |
Why?
|
Isoflurane | 2 | 2021 | 384 | 0.540 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 578 | 0.510 |
Why?
|
Respiration, Artificial | 12 | 2023 | 2709 | 0.510 |
Why?
|
Phosgene | 1 | 2015 | 2 | 0.500 |
Why?
|
Chemical Warfare Agents | 1 | 2015 | 19 | 0.490 |
Why?
|
Anesthetics, Inhalation | 2 | 2021 | 573 | 0.480 |
Why?
|
Eicosanoids | 1 | 2017 | 284 | 0.470 |
Why?
|
Docosahexaenoic Acids | 3 | 2021 | 916 | 0.470 |
Why?
|
Nitric Oxide Synthase | 5 | 2004 | 911 | 0.430 |
Why?
|
Lipopolysaccharides | 12 | 2020 | 2216 | 0.420 |
Why?
|
Polydeoxyribonucleotides | 3 | 2024 | 136 | 0.420 |
Why?
|
Tight Junctions | 1 | 2015 | 330 | 0.410 |
Why?
|
Natural Killer T-Cells | 3 | 2024 | 319 | 0.400 |
Why?
|
Carbon Monoxide | 5 | 2018 | 560 | 0.400 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2035 | 0.380 |
Why?
|
Metabolomics | 7 | 2024 | 1668 | 0.380 |
Why?
|
Promoter Regions, Genetic | 12 | 2018 | 5786 | 0.360 |
Why?
|
Anemia | 1 | 2020 | 1511 | 0.360 |
Why?
|
Blood Coagulation Disorders | 2 | 2021 | 349 | 0.350 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2023 | 5753 | 0.350 |
Why?
|
Cytokines | 12 | 2024 | 7421 | 0.320 |
Why?
|
Neutrophils | 10 | 2022 | 3776 | 0.320 |
Why?
|
Hospital Mortality | 11 | 2022 | 5343 | 0.310 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 3 | 2019 | 146 | 0.310 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2023 | 3251 | 0.310 |
Why?
|
Pulmonary Atelectasis | 2 | 2020 | 161 | 0.300 |
Why?
|
Dendritic Cells | 3 | 2018 | 2747 | 0.300 |
Why?
|
Leukocytes | 4 | 2021 | 2027 | 0.300 |
Why?
|
Multiple Organ Failure | 3 | 2021 | 390 | 0.300 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1240 | 0.290 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 2 | 2005 | 44 | 0.290 |
Why?
|
P-Selectin | 1 | 2010 | 597 | 0.290 |
Why?
|
Endothelial Cells | 7 | 2021 | 3584 | 0.280 |
Why?
|
Mice | 43 | 2024 | 81818 | 0.280 |
Why?
|
Catheterization, Central Venous | 1 | 2012 | 539 | 0.270 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1560 | 0.270 |
Why?
|
Shock, Septic | 3 | 2024 | 774 | 0.260 |
Why?
|
Heparin | 4 | 2021 | 1630 | 0.260 |
Why?
|
Animals | 55 | 2024 | 168759 | 0.240 |
Why?
|
Acute Kidney Injury | 3 | 2023 | 1946 | 0.240 |
Why?
|
Mice, Inbred C57BL | 17 | 2024 | 22331 | 0.240 |
Why?
|
Bacteriological Techniques | 1 | 2006 | 276 | 0.230 |
Why?
|
Monocytes | 4 | 2021 | 2595 | 0.230 |
Why?
|
Humans | 101 | 2024 | 765956 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7425 | 0.220 |
Why?
|
Polyamines | 1 | 2024 | 130 | 0.220 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2013 | 3247 | 0.210 |
Why?
|
DNA, Mitochondrial | 3 | 2018 | 869 | 0.210 |
Why?
|
Vasculitis | 2 | 2021 | 527 | 0.210 |
Why?
|
Discriminant Analysis | 3 | 2018 | 222 | 0.210 |
Why?
|
Preoperative Care | 1 | 2012 | 2267 | 0.210 |
Why?
|
Disease Models, Animal | 12 | 2021 | 18294 | 0.200 |
Why?
|
Male | 59 | 2024 | 363691 | 0.200 |
Why?
|
Blood Gas Analysis | 3 | 2018 | 380 | 0.190 |
Why?
|
Middle Aged | 38 | 2024 | 223004 | 0.190 |
Why?
|
Gastric Juice | 1 | 2021 | 59 | 0.190 |
Why?
|
Kynurenine | 1 | 2022 | 142 | 0.190 |
Why?
|
Phagocytosis | 4 | 2018 | 1520 | 0.190 |
Why?
|
Pulmonary Surfactants | 2 | 2021 | 169 | 0.190 |
Why?
|
Heme Oxygenase-1 | 4 | 2008 | 364 | 0.190 |
Why?
|
Bronchiolitis Obliterans | 2 | 2014 | 221 | 0.190 |
Why?
|
Female | 57 | 2024 | 396101 | 0.190 |
Why?
|
Lung Diseases | 1 | 2011 | 1940 | 0.190 |
Why?
|
Growth Differentiation Factor 2 | 1 | 2021 | 27 | 0.180 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2018 | 755 | 0.180 |
Why?
|
Endothelium, Vascular | 3 | 2024 | 4427 | 0.180 |
Why?
|
Respiratory Therapy | 2 | 2018 | 124 | 0.180 |
Why?
|
Myositis | 1 | 2024 | 270 | 0.180 |
Why?
|
Inflammation | 9 | 2024 | 10850 | 0.180 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2017 | 622 | 0.180 |
Why?
|
Interferon-gamma | 4 | 2020 | 3160 | 0.170 |
Why?
|
Electricity | 2 | 2021 | 174 | 0.170 |
Why?
|
Mitochondrial Diseases | 1 | 2024 | 345 | 0.170 |
Why?
|
Membrane Glycoproteins | 3 | 2018 | 3690 | 0.170 |
Why?
|
Administration, Inhalation | 3 | 2018 | 1154 | 0.170 |
Why?
|
Partial Thromboplastin Time | 2 | 2020 | 202 | 0.170 |
Why?
|
Static Electricity | 1 | 2020 | 259 | 0.170 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 74 | 0.170 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1327 | 0.170 |
Why?
|
Lung Diseases, Interstitial | 2 | 2020 | 939 | 0.170 |
Why?
|
Inflammation Mediators | 4 | 2021 | 1884 | 0.170 |
Why?
|
Bilirubin | 2 | 2023 | 439 | 0.170 |
Why?
|
NF-kappa B | 5 | 2018 | 2485 | 0.170 |
Why?
|
Metabolome | 2 | 2017 | 1005 | 0.170 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2020 | 323 | 0.160 |
Why?
|
Endothelium | 1 | 2021 | 767 | 0.150 |
Why?
|
Critical Care | 4 | 2022 | 2712 | 0.150 |
Why?
|
Asthma | 5 | 2014 | 6270 | 0.150 |
Why?
|
Renin-Angiotensin System | 1 | 2023 | 737 | 0.150 |
Why?
|
Gene Expression | 5 | 2016 | 7584 | 0.150 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2019 | 195 | 0.150 |
Why?
|
Immunity, Cellular | 2 | 2021 | 1555 | 0.150 |
Why?
|
Mucin-5B | 1 | 2018 | 148 | 0.150 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2017 | 49 | 0.150 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 291 | 0.150 |
Why?
|
Bronchoscopy | 1 | 2024 | 909 | 0.150 |
Why?
|
Pandemics | 7 | 2022 | 8701 | 0.140 |
Why?
|
Phospholipase D | 1 | 2018 | 71 | 0.140 |
Why?
|
Genes, Dominant | 2 | 2018 | 856 | 0.140 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 1999 | 345 | 0.140 |
Why?
|
Escherichia coli Infections | 3 | 2018 | 519 | 0.140 |
Why?
|
Respiratory Mucosa | 2 | 2015 | 438 | 0.140 |
Why?
|
Hypotension | 2 | 2018 | 885 | 0.140 |
Why?
|
Authorship | 1 | 2020 | 288 | 0.140 |
Why?
|
Reticulocytes | 1 | 2017 | 287 | 0.130 |
Why?
|
Aged | 28 | 2024 | 171114 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2017 | 190 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 431 | 0.130 |
Why?
|
Thorax | 1 | 2019 | 554 | 0.130 |
Why?
|
Plasma | 1 | 2020 | 579 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1061 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1514 | 0.130 |
Why?
|
Adult | 23 | 2024 | 223038 | 0.130 |
Why?
|
Mice, Transgenic | 6 | 2020 | 9550 | 0.130 |
Why?
|
Bicarbonates | 1 | 2017 | 293 | 0.130 |
Why?
|
Education | 1 | 2018 | 533 | 0.130 |
Why?
|
Antigen-Presenting Cells | 2 | 2012 | 962 | 0.130 |
Why?
|
Neutropenia | 1 | 2021 | 893 | 0.120 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2018 | 702 | 0.120 |
Why?
|
Bacteria | 2 | 2020 | 2209 | 0.120 |
Why?
|
Angiopoietin-2 | 1 | 2016 | 187 | 0.120 |
Why?
|
Creatine | 1 | 2017 | 424 | 0.120 |
Why?
|
Interleukin-6 | 4 | 2021 | 3222 | 0.120 |
Why?
|
Airway Resistance | 2 | 2016 | 407 | 0.120 |
Why?
|
Bacteremia | 3 | 2024 | 989 | 0.120 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 3715 | 0.120 |
Why?
|
Antigens, CD1d | 3 | 2024 | 226 | 0.120 |
Why?
|
Immunoglobulins | 1 | 2018 | 852 | 0.120 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2210 | 0.120 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 575 | 0.120 |
Why?
|
Biomimetics | 1 | 2016 | 168 | 0.120 |
Why?
|
Liver | 1 | 2010 | 7562 | 0.110 |
Why?
|
Egg Hypersensitivity | 1 | 2014 | 47 | 0.110 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2015 | 133 | 0.110 |
Why?
|
Base Sequence | 4 | 2008 | 12403 | 0.110 |
Why?
|
Cells, Cultured | 7 | 2018 | 18973 | 0.110 |
Why?
|
Peritonitis | 2 | 2013 | 369 | 0.110 |
Why?
|
Protein Kinases | 2 | 2018 | 1611 | 0.110 |
Why?
|
Transcription Factors | 7 | 2004 | 12131 | 0.110 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 858 | 0.110 |
Why?
|
Cell Adhesion | 1 | 2020 | 3089 | 0.110 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 986 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1792 | 0.110 |
Why?
|
Blood Cells | 1 | 2016 | 307 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 590 | 0.110 |
Why?
|
N-Formylmethionine | 2 | 2024 | 14 | 0.110 |
Why?
|
Biomedical Research | 2 | 2020 | 3458 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 3 | 2014 | 190 | 0.110 |
Why?
|
DNA-Binding Proteins | 7 | 2014 | 9601 | 0.110 |
Why?
|
Immunoglobulin E | 2 | 2014 | 1481 | 0.110 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2019 | 788 | 0.110 |
Why?
|
Lymphoma, T-Cell | 2 | 2007 | 309 | 0.110 |
Why?
|
Busulfan | 1 | 2014 | 264 | 0.100 |
Why?
|
Cathepsins | 2 | 2006 | 242 | 0.100 |
Why?
|
Vasoconstrictor Agents | 1 | 2017 | 655 | 0.100 |
Why?
|
Bronchi | 3 | 2012 | 843 | 0.100 |
Why?
|
Macrophages | 6 | 2018 | 5772 | 0.100 |
Why?
|
Massachusetts | 4 | 2020 | 8871 | 0.100 |
Why?
|
Receptors, IgE | 1 | 2014 | 374 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2018 | 906 | 0.100 |
Why?
|
Severity of Illness Index | 6 | 2020 | 15880 | 0.100 |
Why?
|
Publishing | 1 | 2020 | 835 | 0.100 |
Why?
|
Republic of Korea | 3 | 2021 | 588 | 0.100 |
Why?
|
Protein Binding | 6 | 2014 | 9296 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.100 |
Why?
|
Inflammasomes | 2 | 2022 | 543 | 0.100 |
Why?
|
Myeloid Cells | 2 | 2021 | 839 | 0.100 |
Why?
|
Blood Vessels | 1 | 2018 | 1113 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2018 | 4348 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2018 | 1028 | 0.100 |
Why?
|
DNA Helicases | 1 | 2017 | 852 | 0.100 |
Why?
|
Models, Animal | 2 | 2012 | 2120 | 0.100 |
Why?
|
Anticoagulants | 4 | 2021 | 4862 | 0.100 |
Why?
|
Autoradiography | 1 | 2013 | 723 | 0.100 |
Why?
|
Mice, Knockout | 9 | 2020 | 14447 | 0.100 |
Why?
|
Retinoids | 1 | 2012 | 99 | 0.100 |
Why?
|
Immunomodulation | 1 | 2016 | 547 | 0.100 |
Why?
|
Sheep | 3 | 2020 | 1440 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2017 | 4913 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2018 | 2024 | 0.090 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2016 | 426 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 504 | 0.090 |
Why?
|
Blood Group Incompatibility | 1 | 2012 | 134 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2056 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2020 | 2324 | 0.090 |
Why?
|
Outpatients | 1 | 1999 | 1595 | 0.090 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 594 | 0.090 |
Why?
|
Gene Targeting | 2 | 2011 | 841 | 0.090 |
Why?
|
Bronchial Hyperreactivity | 1 | 2012 | 300 | 0.090 |
Why?
|
AT Rich Sequence | 1 | 2010 | 10 | 0.090 |
Why?
|
Intestinal Mucosa | 2 | 2012 | 3046 | 0.090 |
Why?
|
Apoptosis | 4 | 2021 | 9514 | 0.090 |
Why?
|
Cell Separation | 1 | 2016 | 1718 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2023 | 81515 | 0.090 |
Why?
|
Maternal-Fetal Exchange | 1 | 2012 | 453 | 0.080 |
Why?
|
Case-Control Studies | 8 | 2021 | 22222 | 0.080 |
Why?
|
Malnutrition | 1 | 2016 | 629 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 1857 | 0.080 |
Why?
|
Netropsin | 1 | 2009 | 3 | 0.080 |
Why?
|
HMGA Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 1999 | 2080 | 0.080 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 2012 | 220 | 0.080 |
Why?
|
Graft vs Host Disease | 3 | 2021 | 3078 | 0.080 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 11888 | 0.080 |
Why?
|
Hospitalization | 4 | 2023 | 10808 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59488 | 0.080 |
Why?
|
Multivariate Analysis | 5 | 2020 | 12057 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2018 | 16047 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6493 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2949 | 0.080 |
Why?
|
Up-Regulation | 3 | 2016 | 4137 | 0.080 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 1668 | 0.080 |
Why?
|
Cohort Studies | 10 | 2023 | 41647 | 0.080 |
Why?
|
Signal Transduction | 5 | 2021 | 23600 | 0.080 |
Why?
|
Registries | 3 | 2019 | 8297 | 0.070 |
Why?
|
Leukocyte Count | 2 | 2019 | 1602 | 0.070 |
Why?
|
Transcription, Genetic | 5 | 2020 | 7599 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2020 | 4494 | 0.070 |
Why?
|
APACHE | 2 | 2019 | 268 | 0.070 |
Why?
|
Forced Expiratory Volume | 3 | 2014 | 1828 | 0.070 |
Why?
|
Boston | 5 | 2018 | 9338 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-ets | 3 | 2003 | 312 | 0.070 |
Why?
|
New York | 2 | 2021 | 880 | 0.070 |
Why?
|
Antigens, CD | 1 | 2018 | 4025 | 0.070 |
Why?
|
Interferon Regulatory Factor-1 | 2 | 2004 | 70 | 0.070 |
Why?
|
Antimetabolites | 1 | 2008 | 127 | 0.070 |
Why?
|
HMGB1 Protein | 1 | 2008 | 139 | 0.070 |
Why?
|
Genetic Variation | 1 | 2002 | 6610 | 0.070 |
Why?
|
Carboxyhemoglobin | 2 | 2018 | 83 | 0.070 |
Why?
|
Mast Cells | 1 | 2014 | 1412 | 0.070 |
Why?
|
Radiopharmaceuticals | 2 | 2016 | 2699 | 0.070 |
Why?
|
MicroRNAs | 2 | 2013 | 3785 | 0.070 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1635 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1746 | 0.070 |
Why?
|
Cell Line | 8 | 2012 | 15543 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2598 | 0.070 |
Why?
|
Bone Marrow Transplantation | 3 | 2021 | 2729 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 2 | 2011 | 1365 | 0.070 |
Why?
|
Phenotype | 2 | 2022 | 16721 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2012 | 1183 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3956 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5197 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1663 | 0.060 |
Why?
|
RNA, Messenger | 8 | 2017 | 12769 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4241 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2016 | 2003 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1087 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2008 | 1167 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3316 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1897 | 0.060 |
Why?
|
Lymphoma, B-Cell | 2 | 2014 | 943 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 4405 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8611 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2016 | 3564 | 0.060 |
Why?
|
Sulfoglycosphingolipids | 1 | 2024 | 32 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4778 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2004 | 32 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3425 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2004 | 30 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2020 | 9249 | 0.060 |
Why?
|
Surface Tension | 1 | 2004 | 43 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3801 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2020 | 3675 | 0.060 |
Why?
|
Phosphoproteins | 2 | 2004 | 2446 | 0.060 |
Why?
|
Radiation Chimera | 1 | 2004 | 216 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 40065 | 0.060 |
Why?
|
Kidney | 2 | 2016 | 7066 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2004 | 456 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2018 | 2229 | 0.060 |
Why?
|
Logistic Models | 4 | 2020 | 13266 | 0.050 |
Why?
|
Vitamin D | 1 | 2017 | 3272 | 0.050 |
Why?
|
Macrophages, Peritoneal | 1 | 2004 | 243 | 0.050 |
Why?
|
Proteomics | 2 | 2016 | 3910 | 0.050 |
Why?
|
History, 19th Century | 1 | 2006 | 711 | 0.050 |
Why?
|
Blotting, Western | 3 | 2017 | 5020 | 0.050 |
Why?
|
Cell Death | 2 | 2019 | 1679 | 0.050 |
Why?
|
Intestines | 1 | 2012 | 1906 | 0.050 |
Why?
|
Cell Communication | 1 | 2010 | 1660 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2006 | 4520 | 0.050 |
Why?
|
Fatty Acids | 2 | 2022 | 1806 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 18071 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2024 | 239 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2016 | 694 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1151 | 0.050 |
Why?
|
Renin | 1 | 2024 | 647 | 0.050 |
Why?
|
Occupational Exposure | 1 | 2012 | 1805 | 0.050 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2002 | 128 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1968 | 0.050 |
Why?
|
Aerosols | 1 | 2004 | 633 | 0.050 |
Why?
|
Methionine | 1 | 2024 | 569 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2023 | 281 | 0.050 |
Why?
|
Smoking | 3 | 2013 | 9081 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 207 | 0.050 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2021 | 24 | 0.050 |
Why?
|
Utah | 1 | 2021 | 130 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2023 | 2354 | 0.040 |
Why?
|
ROC Curve | 2 | 2020 | 3620 | 0.040 |
Why?
|
Swine | 2 | 2021 | 5988 | 0.040 |
Why?
|
Immunologic Tests | 1 | 2021 | 101 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11022 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4588 | 0.040 |
Why?
|
Simvastatin | 1 | 2023 | 345 | 0.040 |
Why?
|
Ketones | 1 | 2021 | 183 | 0.040 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2024 | 340 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 2021 | 167 | 0.040 |
Why?
|
Viral Tropism | 1 | 2021 | 101 | 0.040 |
Why?
|
Vital Capacity | 2 | 2014 | 995 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2023 | 700 | 0.040 |
Why?
|
Pneumonia | 1 | 2012 | 2157 | 0.040 |
Why?
|
Prothrombin Time | 1 | 2020 | 116 | 0.040 |
Why?
|
Resuscitation | 1 | 2024 | 679 | 0.040 |
Why?
|
United States | 7 | 2023 | 72898 | 0.040 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2022 | 266 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 651 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2012 | 1915 | 0.040 |
Why?
|
Immunity, Innate | 2 | 2012 | 3081 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2531 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2020 | 381 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2016 | 6220 | 0.040 |
Why?
|
Organ Specificity | 2 | 2021 | 1965 | 0.040 |
Why?
|
Glucuronidase | 1 | 2021 | 203 | 0.040 |
Why?
|
Thrombotic Microangiopathies | 1 | 2021 | 125 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2003 | 710 | 0.040 |
Why?
|
Blotting, Northern | 2 | 2014 | 1546 | 0.040 |
Why?
|
Candida | 1 | 2020 | 172 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.040 |
Why?
|
Survival Analysis | 3 | 2021 | 10070 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22340 | 0.040 |
Why?
|
Leukocyte Elastase | 1 | 2019 | 113 | 0.040 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2021 | 221 | 0.040 |
Why?
|
Charities | 1 | 2018 | 35 | 0.040 |
Why?
|
Lactic Acid | 1 | 2024 | 1137 | 0.040 |
Why?
|
Risk Assessment | 3 | 2020 | 24283 | 0.040 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2011 | 295 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2014 | 870 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3850 | 0.040 |
Why?
|
Foundations | 1 | 2018 | 95 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1689 | 0.040 |
Why?
|
Linear Models | 2 | 2018 | 5876 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2021 | 412 | 0.040 |
Why?
|
Training Support | 1 | 2018 | 109 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 428 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2021 | 951 | 0.040 |
Why?
|
Sp3 Transcription Factor | 2 | 2011 | 30 | 0.040 |
Why?
|
Thrombophilia | 1 | 2021 | 308 | 0.040 |
Why?
|
Color Vision Defects | 1 | 1998 | 27 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 472 | 0.040 |
Why?
|
Enoxaparin | 1 | 2020 | 390 | 0.040 |
Why?
|
Kidney Tubules | 1 | 2020 | 453 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2761 | 0.040 |
Why?
|
Amino Acids | 1 | 2024 | 1709 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 29921 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2002 | 1997 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 600 | 0.040 |
Why?
|
Candidiasis | 1 | 2020 | 371 | 0.040 |
Why?
|
Viremia | 1 | 2020 | 727 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2018 | 6203 | 0.040 |
Why?
|
Antigens, CD20 | 1 | 2018 | 198 | 0.030 |
Why?
|
Stomach | 1 | 2021 | 699 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 65189 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2022 | 1866 | 0.030 |
Why?
|
3T3 Cells | 3 | 2003 | 1081 | 0.030 |
Why?
|
Odds Ratio | 2 | 2020 | 9649 | 0.030 |
Why?
|
Color Perception | 1 | 1998 | 212 | 0.030 |
Why?
|
Hypoxanthine | 1 | 2016 | 28 | 0.030 |
Why?
|
Fibrinogen | 1 | 2020 | 895 | 0.030 |
Why?
|
Response Elements | 2 | 2012 | 307 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2001 | 682 | 0.030 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2016 | 66 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2019 | 559 | 0.030 |
Why?
|
Genetic Markers | 1 | 2002 | 2601 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2020 | 596 | 0.030 |
Why?
|
Trans-Activators | 1 | 2006 | 2850 | 0.030 |
Why?
|
Tidal Volume | 1 | 2018 | 519 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2020 | 15747 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2780 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2002 | 1744 | 0.030 |
Why?
|
Bone Marrow Cells | 2 | 2020 | 2412 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3271 | 0.030 |
Why?
|
Podocytes | 1 | 2020 | 391 | 0.030 |
Why?
|
Binding Sites | 4 | 2009 | 6001 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8102 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12795 | 0.030 |
Why?
|
Gene Frequency | 1 | 2002 | 3624 | 0.030 |
Why?
|
Extracorporeal Circulation | 1 | 2016 | 182 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2143 | 0.030 |
Why?
|
Autoantibodies | 1 | 2024 | 2113 | 0.030 |
Why?
|
Glutamates | 1 | 2016 | 384 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 791 | 0.030 |
Why?
|
Cell Migration Assays | 1 | 2014 | 22 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2017 | 647 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2263 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2003 | 2968 | 0.030 |
Why?
|
Papain | 1 | 2014 | 66 | 0.030 |
Why?
|
Granulocytes | 1 | 2016 | 549 | 0.030 |
Why?
|
Heart Arrest | 1 | 2024 | 1516 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2006 | 3681 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2261 | 0.030 |
Why?
|
Awards and Prizes | 1 | 2018 | 364 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2652 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1347 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1545 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2024 | 1660 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2395 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1617 | 0.030 |
Why?
|
Glutathione | 1 | 2016 | 588 | 0.030 |
Why?
|
Zymosan | 1 | 2013 | 128 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 1693 | 0.030 |
Why?
|
Papio | 1 | 2015 | 671 | 0.030 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 394 | 0.030 |
Why?
|
Hematologic Diseases | 1 | 2017 | 500 | 0.030 |
Why?
|
Genotype | 2 | 2011 | 13024 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1628 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2014 | 152 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2014 | 651 | 0.030 |
Why?
|
Fibroblasts | 3 | 2011 | 4159 | 0.030 |
Why?
|
Animals, Newborn | 2 | 2012 | 2669 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1528 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1718 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15398 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10563 | 0.030 |
Why?
|
Macaca | 1 | 2014 | 413 | 0.030 |
Why?
|
Cytoplasm | 1 | 2017 | 1500 | 0.030 |
Why?
|
Bronchography | 1 | 2012 | 70 | 0.030 |
Why?
|
Purines | 1 | 2016 | 615 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2630 | 0.030 |
Why?
|
Ovalbumin | 1 | 2014 | 674 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15839 | 0.030 |
Why?
|
alpha Karyopherins | 1 | 2012 | 42 | 0.030 |
Why?
|
Chemokine CXCL6 | 1 | 2012 | 14 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1602 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2021 | 1067 | 0.020 |
Why?
|
Oxazolone | 1 | 2012 | 59 | 0.020 |
Why?
|
Career Choice | 1 | 2018 | 769 | 0.020 |
Why?
|
RNA, Viral | 1 | 2020 | 2864 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 493 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 322 | 0.020 |
Why?
|
Electric Impedance | 1 | 2016 | 794 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2218 | 0.020 |
Why?
|
Receptors, CXCR | 1 | 2012 | 52 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2014 | 480 | 0.020 |
Why?
|
Triage | 1 | 1999 | 996 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2018 | 921 | 0.020 |
Why?
|
Prospective Studies | 4 | 2018 | 54806 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7478 | 0.020 |
Why?
|
Germ-Free Life | 1 | 2012 | 187 | 0.020 |
Why?
|
Airway Remodeling | 1 | 2012 | 134 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2008 | 17594 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 1 | 2012 | 229 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2014 | 687 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3386 | 0.020 |
Why?
|
Caspase 1 | 1 | 2012 | 227 | 0.020 |
Why?
|
Positron-Emission Tomography | 2 | 2018 | 6547 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 527 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1999 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 498 | 0.020 |
Why?
|
Sequence Deletion | 2 | 2008 | 1495 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9524 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2011 | 366 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2011 | 378 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 596 | 0.020 |
Why?
|
Deafness | 1 | 2014 | 460 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 1999 | 1672 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1308 | 0.020 |
Why?
|
Warfarin | 1 | 1999 | 1494 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1238 | 0.020 |
Why?
|
Autoimmunity | 1 | 2018 | 1354 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3708 | 0.020 |
Why?
|
E-Selectin | 1 | 2012 | 576 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1080 | 0.020 |
Why?
|
Cell Movement | 2 | 2014 | 5194 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20125 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 470 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 562 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2394 | 0.020 |
Why?
|
Octamer Transcription Factors | 1 | 2009 | 18 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1187 | 0.020 |
Why?
|
Transition Temperature | 1 | 2009 | 33 | 0.020 |
Why?
|
Biliverdine | 1 | 2008 | 28 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3211 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 752 | 0.020 |
Why?
|
Ileum | 1 | 2011 | 558 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 857 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 1999 | 2172 | 0.020 |
Why?
|
Cataract | 1 | 2014 | 837 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4752 | 0.020 |
Why?
|
Erythrocytes | 1 | 2017 | 2395 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 1348 | 0.020 |
Why?
|
Nutritional Status | 1 | 2016 | 1620 | 0.020 |
Why?
|
Microscopy | 1 | 2013 | 901 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2535 | 0.020 |
Why?
|
DNA | 3 | 2009 | 7202 | 0.020 |
Why?
|
Antioxidants | 1 | 2015 | 1670 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3481 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1882 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5501 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5993 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 734 | 0.020 |
Why?
|
Allergens | 1 | 2014 | 1436 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8041 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 59886 | 0.020 |
Why?
|
Transfection | 2 | 2006 | 5743 | 0.020 |
Why?
|
Enterococcus faecalis | 1 | 2008 | 244 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3819 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2418 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10383 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4528 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2832 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 499 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2013 | 822 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6485 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3513 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2728 | 0.020 |
Why?
|
Students, Medical | 1 | 2018 | 1959 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2008 | 339 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1789 | 0.020 |
Why?
|
Ethylnitrosourea | 1 | 2004 | 50 | 0.010 |
Why?
|
Risk Factors | 3 | 2018 | 74836 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2006 | 271 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2899 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14749 | 0.010 |
Why?
|
Colon | 1 | 2012 | 1795 | 0.010 |
Why?
|
Patient Selection | 1 | 2016 | 4255 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4618 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7232 | 0.010 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2003 | 165 | 0.010 |
Why?
|
Algorithms | 2 | 2013 | 14071 | 0.010 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2002 | 21 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20660 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 88832 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14652 | 0.010 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2002 | 147 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10429 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2004 | 576 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6255 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21480 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2002 | 362 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 431 | 0.010 |
Why?
|
Transcription Initiation Site | 1 | 2002 | 190 | 0.010 |
Why?
|
Sp1 Transcription Factor | 1 | 2002 | 143 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23707 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4209 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2002 | 1056 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6897 | 0.010 |
Why?
|
Leukotriene Antagonists | 1 | 2001 | 124 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8067 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1679 | 0.010 |
Why?
|
Dementia | 1 | 2014 | 2744 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2003 | 637 | 0.010 |
Why?
|
Models, Immunological | 1 | 2002 | 517 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2001 | 345 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2002 | 1243 | 0.010 |
Why?
|
Oncogenes | 1 | 2004 | 1235 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2002 | 931 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26313 | 0.010 |
Why?
|
Flicker Fusion | 1 | 1998 | 14 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 17075 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3421 | 0.010 |
Why?
|
Adaptation, Ocular | 1 | 1998 | 89 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27178 | 0.010 |
Why?
|
DNA Methylation | 1 | 2012 | 4424 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1998 | 288 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4562 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4165 | 0.010 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 1998 | 184 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10261 | 0.010 |
Why?
|
Escherichia coli | 1 | 2008 | 4214 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2003 | 1995 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1657 | 0.010 |
Why?
|
Kinetics | 1 | 2002 | 6274 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8731 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1998 | 820 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13400 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2001 | 2132 | 0.010 |
Why?
|
Heterozygote | 1 | 1998 | 2794 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 30258 | 0.010 |
Why?
|
Peptides | 1 | 2002 | 4331 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36532 | 0.000 |
Why?
|
Visual Acuity | 1 | 1998 | 2708 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9443 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2003 | 7851 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2002 | 13648 | 0.000 |
Why?
|